Impax Asset Management Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-21,773
Closed -$611K – 374
2023
Q3
$611K Sell
21,773
-401
-2% -$13.8K ﹤0.01% 310
2023
Q2
$818K Sell
22,174
-18,986
-46% -$580K ﹤0.01% 296
2023
Q1
$1.23M Sell
41,160
-28,925
-41% -$953K 0.01% 263
2022
Q4
$2.15M Sell
70,085
-2,755
-4% -$82.7K 0.01% 223
2022
Q3
$1.8M Buy
72,840
+63,403
+672% +$2.09M 0.01% 228
2022
Q2
$302K Hold
9,437
– – ﹤0.01% 352
2022
Q1
$297K Sell
9,437
-48
-0.5% -$1.5K ﹤0.01% 375
2021
Q4
$318K Sell
9,485
-259
-3% -$8.07K ﹤0.01% 376
2021
Q3
$283K Hold
9,744
– – ﹤0.01% 365
2021
Q2
$339K Hold
9,744
– – ﹤0.01% 355
2021
Q1
$272K Buy
+9,744
New +$259K ﹤0.01% 380

Other funds holding CC

Impax Asset Management Group's CC Position: Q4 2023 in Review

Impax Asset Management Group sold out of Chemours (CC) in Q4 2023, closing a stake of 21,773 shares — an estimated $611K sold.

Impax Asset Management Group first reported a position in CC in Q1 2021 and held it in 11 quarters. The position peaked at $2.15M in Q4 2022. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • Impax Asset Management Group reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • Impax Asset Management Group sold 21,773 Chemours shares in Q4 2023, an estimated $611K.
  • Impax Asset Management Group first reported a position in Chemours in Q1 2021 and held it in 11 quarters.
  • Impax Asset Management Group's Chemours position peaked at $2.15M in Q4 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Impax Asset Management Group's 13F filing for Q4 2023, filed 26 Jan 2024.